SecondWave Systems raises $7M Series A to Accelerate Clinical Development of a Novel Ultrasound-Based Anti-Inflammatory Therapy
- SecondWave Systems, Inc., a St. Paul company, finalized a $7 million Series A funding on April 8, 2025.
- SecondWave requires funding to advance its novel ultrasound-based treatment for inflammatory disorders into clinical studies.
- Treo Ventures and a healthcare strategic led the financing, alongside Scientific Health Development, and University of Minnesota's Discovery Capital.
- CEO Anuj Bhardwaj stated the company is excited to enter the next phase of development with new investor partners.
- SecondWave will use the funds to support its next clinical study, expanding on positive results from their first study.
24 Articles
24 Articles

SecondWave Systems raises $7M Series A to Accelerate Clinical Development of a Novel Ultrasound-Based Anti-Inflammatory Therapy
ST. PAUL, Minn., April 8, 2025 /PRNewswire/ -- SecondWave Systems, Inc., a clinical stage medical device company developing a novel ultrasound-based treatment for inflammatory disorders, announced today that it has closed a $7M Series A financing round. The financing was…
SecondWave Systems Raises $7M in Series A Funding
SecondWave Systems, Inc., a St. Paul, MN-based clinical stage medical device company, raised $7M Series A funding. The round was led by Treo Ventures and a major healthcare strategic, with participation from Scientific Health Development and the University of Minnesota’s Discovery Capital and SSBCI funds. The company intends to support its next clinical study, leveraging the success of their […] The post SecondWave Systems Raises $7M in Series A…
Coverage Details
Bias Distribution
- 100% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage